For companies in the US pharma supply chain, 2019 is going to be the year of an important milestone of the Drug Supply Chain Security Act (DSCSA). In November, wholesale distributors will be required to begin issuing verification requests to manufacturers, at the Standardized Numerical Identifier (SNI) level, for any returned drug that is still saleable, before they resell it. I’ve written a lot about this change in the past.
The Healthcare Distribution Alliance (HDA) has facilitated the design and development of an architecture called the Verification Router Service (VRS) (see “First Meeting of the HDA Verification Router Service Task Force”). VRS is intended to be used by wholesale distributors to submit these verification requests to the appropriate manufacturer for a fast verification response. That’s why manufacturers need to take notice. It’s a complex, supply chain-wide solution that <continue reading FREE on C4SCS website>.